Century Therapeutics, Inc.
IPSC
$0.537
$0.0173.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.44% | 4.57% | 6.26% | 10.24% | -24.35% |
| Total Depreciation and Amortization | -6.59% | -1.55% | 7.05% | 10.94% | 25.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -38.84% | -60.18% | -104.49% | 18.80% | 282.27% |
| Change in Net Operating Assets | 129.92% | -114.91% | -82.56% | -127.40% | -212.35% |
| Cash from Operations | 7.65% | -107.58% | -41.98% | -3.52% | -14.51% |
| Capital Expenditure | 84.29% | 124.62% | 94.11% | 89.20% | 84.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.18% | 412.88% | -309.09% | -66.75% | 881.60% |
| Cash from Investing | 64.52% | 829.55% | -585.57% | -63.17% | 535.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 24,798.33% | -16.13% | -18.30% | -- |
| Repurchase of Common Stock | -69.10% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -69.10% | -9.00% | 660.41% | 3,961.38% | -474.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.42% | 221.99% | 79.91% | -119.95% | 70.53% |